Remaining Challenges With Transcatheter Left Atrial Appendage Closure

Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhouli, Mohamad, Holmes, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Concise Review for Clinicians
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528944/
https://www.ncbi.nlm.nih.gov/pubmed/33012352
http://dx.doi.org/10.1016/j.mayocp.2020.07.032
_version_ 1783589352156168192
author Alkhouli, Mohamad
Holmes, David R.
author_facet Alkhouli, Mohamad
Holmes, David R.
author_sort Alkhouli, Mohamad
collection PubMed
description Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However, certain issues remain unresolved with the technology. Knowledge of these issues, their significance, and the current and future efforts to resolve them is key for proper informed decision making by physicians and patients.
format Online
Article
Text
id pubmed-7528944
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mayo Foundation for Medical Education and Research
record_format MEDLINE/PubMed
spelling pubmed-75289442020-10-02 Remaining Challenges With Transcatheter Left Atrial Appendage Closure Alkhouli, Mohamad Holmes, David R. Mayo Clin Proc Concise Review for Clinicians Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However, certain issues remain unresolved with the technology. Knowledge of these issues, their significance, and the current and future efforts to resolve them is key for proper informed decision making by physicians and patients. Mayo Foundation for Medical Education and Research 2020-10 2020-10-01 /pmc/articles/PMC7528944/ /pubmed/33012352 http://dx.doi.org/10.1016/j.mayocp.2020.07.032 Text en © 2020 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Concise Review for Clinicians
Alkhouli, Mohamad
Holmes, David R.
Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title_full Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title_fullStr Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title_full_unstemmed Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title_short Remaining Challenges With Transcatheter Left Atrial Appendage Closure
title_sort remaining challenges with transcatheter left atrial appendage closure
topic Concise Review for Clinicians
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528944/
https://www.ncbi.nlm.nih.gov/pubmed/33012352
http://dx.doi.org/10.1016/j.mayocp.2020.07.032
work_keys_str_mv AT alkhoulimohamad remainingchallengeswithtranscatheterleftatrialappendageclosure
AT holmesdavidr remainingchallengeswithtranscatheterleftatrialappendageclosure

Ejemplares similares